Page 7 - Pharma

BeiGene & Guangzhou Development District to set up $ 330 mn biologics plant

JV will also provide funding for research and development of biologic drug candidates in China

Germany's Merck plans divestment of biosimilars business

Merck has a strategic alliance with India's Dr Reddy's Labs to co-develop multiple cancer drugs

DSM & Evonik to jointly set up $200-mn omega-3 fatty acids plant in US

The plant, for the first time, will enable production of omega-3 fatty acids without using fish oil

Unichem Laboratories receives US FDA approval for migraine drug

It has received approval for rizatriptan benzoate ODT & rizatriptan benzoate tablets

Global orphan drugs market to reach $ 209 billion by 2022

The market is set to be 21.4% of worldwide prescription sales by 2022, says Evaluate report

Merck's arm Allergopharma opens biopharmaceutical facility in Germany

New production unit, built with an investment of € 42 mn, to expand the company's global capability

Tech Mahindra to buy US-based healthcare IT firm CJS Solutions for $ 100 mn

Move to strengthen its position in healthcare provider space - a focus areas for Tech Mahindra

Zydus settles patent litigation related to seizure drug with US-based firm

As per the pact, Zydus to begin selling a generic version of Supernus' Trokendi XR on Jan 1, 2023

Cipla divests animal health business in South Africa & Sub-Saharan Africa

It will sell this business to Ascendis Health for Rand 375 million (about Rs 192 crores)

Cadila Healthcare's Baddi unit receives 3 observations under Form 483

Observations, given by US FDA, are related to pre-approval inspection for a specific product filed

Herbalife collaborate with Syngene to set nutrition R&D lab in India

It houses a GMP formulation lab to support product testing, sampling & end-product development

Glenmark partners Evestra to market contraceptive product in US

They have signed pact for a generic version of Merck & Co's NuvaRing, a contraceptive vaginal ring

Less than 30% of kidney patients manage to get dialysis in India: Study

Need of the hour is to provide cost-effective, safe and equitable access to dialysis

Valeant increases Salix sales force by 40% to capture untapped market

It will make investment in primary care representatives for key products such as Xifaxan & Relistor

Lupin receives US FDA approval for generic Suprep bowel prep kit

The company has also received US drug regulator's nod for generic Percocet tablet, a pain killer

Zydus Cadila to launch tetravalent influenza vaccine in India

Vaccine offers protection from 4 influenza viruses - H1N1, H3N2, Type B (Brisbane) & Type B (Phuket)

Zydus receives US FDA approval for anti-viral drug oseltamivir

The group has also received the US drug regulator's nod to market anti-bacterial drug, linezolid

Sanofi & Lonza to jointly set up $ 285-mn biologics production facility

The facility, to be built in Switzerland, is expected to be fully operational by 2020

Lupin arm Kyowa inks pact with Astellas Pharma to sell antidepressant drug

As per the deal, Kyowa will exclusively market Astellas' quetiapine fumarate tablet in Japan

Arrival of foreign tourists on medical visa witnessing phenomenal growth

Indian pharma market to reach $ 55 bn by 2020 from $ 36.7 bn in 2016, says Assocham-IITTM study